CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
4.680
-0.090 (-1.89%)
At close: Mar 6, 2026, 4:00 PM EST
4.641
-0.039 (-0.84%)
After-hours: Mar 6, 2026, 7:40 PM EST
CytomX Therapeutics Market Cap
CytomX Therapeutics has a market cap or net worth of $792.96 million as of March 6, 2026. Its market cap has increased by 1,140.94% in one year.
Market Cap
792.96M
Enterprise Value
654.93M
1-Year Change
1,140.94%
Ranking
Category
Stock Price
$4.68
Market Cap Chart
Since October 8, 2015, CytomX Therapeutics's market cap has increased from $7.40M to $792.96M, an increase of 10,615.64%. That is a compound annual growth rate of 56.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 793.00M | 9.86% |
| Dec 31, 2025 | 721.80M | 795.53% |
| Dec 31, 2024 | 80.60M | -22.35% |
| Dec 29, 2023 | 103.80M | -1.80% |
| Dec 30, 2022 | 105.70M | -62.58% |
| Dec 31, 2021 | 282.50M | -6.70% |
| Dec 31, 2020 | 302.80M | -19.81% |
| Dec 31, 2019 | 377.60M | -44.44% |
| Dec 31, 2018 | 679.60M | -16.18% |
| Dec 29, 2017 | 810.80M | 102.65% |
| Dec 30, 2016 | 400.10M | -46.78% |
| Dec 31, 2015 | 751.80M | 10,059.46% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sana Biotechnology | 840.63M |
| Evommune | 835.39M |
| BridgeBio Oncology Therapeutics | 833.48M |
| Xencor | 830.19M |
| KalVista Pharmaceuticals | 820.37M |
| Omeros | 818.19M |
| MapLight Therapeutics | 807.80M |
| MannKind | 804.14M |